Can a New York resident get peptides by telehealth?
Public Health Law Article 29-G (sections 2999-cc and following) limits telehealth to telemedicine, store-and-forward technology, remote patient monitoring, and audio-only telephone communication, and defines store-and-forward as the asynchronous transmission of patient-specific digital images or pre-recorded videos from an originating site to a telehealth provider at a distant site. Providers must hold a New York license and are held to the professional standards of Education Law Title VIII. Because New York's store-and-forward definition is limited to images and videos and does not describe questionnaire-based prescribing, this record leaves asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [2] [3]
How does the New York pharmacy board treat compounding?
| Board | New York State Board of Pharmacy (State Education Department, Office of the Professions) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
In New York, the State Education Department registers pharmacies and licenses pharmacists under Education Law Article 137 (sections 6800 and following), with the State Board of Pharmacy advising on standards and discipline, and Commissioner's regulations in 8 NYCRR Part 63 set practice rules. Education Law section 6808-b requires every nonresident establishment (a pharmacy, manufacturer, wholesaler, or outsourcing facility outside New York, including internet pharmacies) that ships, mails, or delivers prescription drugs to New York patients to register with the Department, be licensed and in good standing in its home state, and keep retrievable records of drugs shipped into New York; 8 NYCRR 63.8 implements that requirement. On sterile compounding standards, 8 NYCRR Part 63 does not adopt USP chapters 795 or 797 by number. Instead, the Regents rule 8 NYCRR 29.2 makes it unprofessional conduct for a health professional to fail to adhere to applicable practice guidelines, as determined by the Commissioner, for compounding sterile drugs and products, and 8 NYCRR 63.7 requires pharmacists to complete at least three hours of compounding continuing education, consistent with current compounding standards, in each registration period beginning on or after January 1, 2023. New York has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [4] [5] [6] [7] [8]
Can you get compounded GLP-1s in New York?
A telehealth GLP-1 program shipping into New York must use a pharmacy registered as a nonresident establishment under Education Law section 6808-b, which patients can verify on the Office of the Professions license lookup. [4] [11]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in New York?
Verified access options
Prescriber licensed in New York, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in New York. Whether questionnaire-only prescribing is permitted is not clearly settled, so expect a live visit.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in New York
Is it legal to buy research peptides in New York?
Education Law Article 137 limits dispensing of prescription drugs to registered pharmacies and licensed practitioners, and section 6808-b requires registration of any out-of-state establishment shipping prescription drugs into New York, including internet sellers. [4] [12]
Peptide-specific notes for New York
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including from a New York-licensed telehealth provider under Public Health Law Article 29-G. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [11] |
| Tirzepatide | Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and an out-of-state pharmacy must be registered under Education Law section 6808-b to ship it into New York. [4] [11] |
Compare: Semaglutide vs tirzepatide.
Frequently asked questions
Can I get a GLP-1 prescription in New York through telehealth?
Yes, from a New York-licensed provider. Public Health Law Article 29-G recognizes telemedicine, store-and-forward, remote monitoring, and audio-only calls, and semaglutide and tirzepatide are not controlled substances. [2]
Does New York's store-and-forward telehealth cover online questionnaires?
Not by its terms. New York defines store-and-forward as the asynchronous transmission of patient-specific digital images or pre-recorded videos, so questionnaire-only prescribing depends on professional standards rather than an express telehealth rule. [3]
Can an out-of-state pharmacy ship compounded peptides to me in New York?
Only if it is registered with the State Education Department as a nonresident establishment under Education Law section 6808-b. Check the Office of the Professions registration lookup before ordering. [4] [5]
Can a New York pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]
From the blog
- Can you get a GLP-1 through telehealth in your state?
Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with ten state examples.
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]New York State Education Department, Office of the Professions: Pharmacy
- [2]New York Public Health Law Article 29-G, Telehealth delivery of services
- [3]New York Public Health Law section 2999-cc, Telehealth definitions
- [4]New York Education Law section 6808-b, Registration of nonresident establishments
- [5]8 NYCRR 63.8, Registration of nonresident establishments
- [6]8 NYCRR Part 63, Pharmacy (Regulations of the Commissioner of Education, including 63.7 continuing education)
- [7]8 NYCRR Part 29, Unprofessional conduct (section 29.2, general provisions for health professions)
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in New York?. https://peptideagent.ai/legal/new-york- HTML link
<a href="https://peptideagent.ai/legal/new-york">Are peptides legal in New York?</a>, PeptideAgent, updated September 22, 2026.